Immunovant IMVT Stock
14.91 USD
{{ price }}
-3.588751%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
2.53B USD
LOW - HIGH [24H]
14.72
-
15.59 USD
VOLUME [24H]
595.48K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.62 USD
Immunovant Price Chart
Immunovant IMVT Financial and Trading Overview
| Immunovant stock price | 14.91 USD |
| Previous Close | 21.29 USD |
| Open | 21.24 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1000 |
| Day's Range | 20.94 - 21.37 USD |
| 52 Week Range | 3.4 - 24.18 USD |
| Volume | 788.79K USD |
| Avg. Volume | 1.04M USD |
| Market Cap | 2.76B USD |
| Beta (5Y Monthly) | 1.006844 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.62 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.23 USD |
IMVT Valuation Measures
| Enterprise Value | 2.4B USD |
| Trailing P/E | N/A |
| Forward P/E | -11.062827 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 7.597986 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -11.539 |
Trading Information
Immunovant Stock Price History
| Beta (5Y Monthly) | 1.006844 |
| 52-Week Change | 488.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24.18 USD |
| 52 Week Low | 3.4 USD |
| 50-Day Moving Average | 18.62 USD |
| 200-Day Moving Average | 14.73 USD |
IMVT Share Statistics
| Avg. Volume (3 month) | 1.04M USD |
| Avg. Daily Volume (10-Days) | 936.23K USD |
| Shares Outstanding | 130.41M |
| Float | 48.42M |
| Short Ratio | 2.76 |
| % Held by Insiders | 58.66% |
| % Held by Institutions | 43.87% |
| Shares Short | 3.43M |
| Short % of Float | 6.12% |
| Short % of Shares Outstanding | 2.63% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.25% |
| Return on Equity (ttm) | -50.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -208083008 USD |
| Net Income Avi to Common (ttm) | -210960000 USD |
| Diluted EPS (ttm) | -1.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 376.53M USD |
| Total Cash Per Share (mrq) | 2.89 USD |
| Total Debt (mrq) | 1.22M USD |
| Total Debt/Equity (mrq) | 0.34 USD |
| Current Ratio (mrq) | 9.339 |
| Book Value Per Share (mrq) | 2.781 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -188192992 USD |
| Levered Free Cash Flow (ttm) | -107818496 USD |
Profile of Immunovant
| Country | United States |
| State | NY |
| City | New York |
| Address | 320 West 37th Street |
| ZIP | 10018 |
| Phone | 917 580 3099 |
| Website | https://immunovant.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 164 |
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Q&A For Immunovant Stock
What is a current IMVT stock price?
Immunovant IMVT stock price today per share is 14.91 USD.
How to purchase Immunovant stock?
You can buy IMVT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunovant?
The stock symbol or ticker of Immunovant is IMVT.
Which industry does the Immunovant company belong to?
The Immunovant industry is Biotechnology.
How many shares does Immunovant have in circulation?
The max supply of Immunovant shares is 169.86M.
What is Immunovant Price to Earnings Ratio (PE Ratio)?
Immunovant PE Ratio is now.
What was Immunovant earnings per share over the trailing 12 months (TTM)?
Immunovant EPS is -2.62 USD over the trailing 12 months.
Which sector does the Immunovant company belong to?
The Immunovant sector is Healthcare.
Immunovant IMVT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16283.51 USD — |
-3.21
|
4.37B USD — | 16283.1 USD — | 16600.37 USD — | — - | 4.37B USD — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 1956.38 USD — |
-1.44
|
— — | 1950.84 USD — | 1985.27 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Other Finance OFIN | 11566.37 USD — |
-2.19
|
— — | 11542.77 USD — | 11782.71 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7941.9 USD — |
-3.5
|
— — | 7927.62 USD — | 8119.29 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3929.03 USD — |
-2.03
|
— — | 3920.09 USD — | 4000.18 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 882.26 USD — |
-1.79
|
— — | 880.7 USD — | 895.82 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 99.27 USD — |
-2.3
|
— — | 99.07 USD — | 102.86 USD — | — - | — — |
- {{ link.label }} {{link}}